ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-21

Reporting Person: Warmuth Michael J (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-21	Option (right to buy)	$39.12	A	107793	Acquired	2024-02-20	Common shares (107793)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,931 on 2/21/2015, 35,931 on 2/21/2016 and 35,931 on 2/21/2017.